Accumulated evidence reveals that LSD1 as an oncogene, participates in promoting tumor progression [22], metastasis [24] and drug resistance [21] which highlights that LSD1 is a highly promising therapeutic target across the cancers. The gene discussed is KDM1A; the disease is neoplasm.